Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 8Active not recruiting 8Not yet recruiting 4Completed 2Terminated 1Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 2Colonic Neoplasms 1

Interventions

pembrolizumab 244Nivolumab 140Cisplatin 135Cyclophosphamide 134Paclitaxel 113Carboplatin 108Gemcitabine 98Radiotherapy 83Dexamethasone 83Docetaxel 77atezolizumab 68Ipilimumab 68Doxorubicin 62Fluorouracil 60Blood Specimen Collection 58Bevacizumab 58fludarabine 54Rituximab 54Etoposide 53Oxaliplatin 52Surveys and Questionnaires 49Lenalidomide 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Cetuximab 44Capecitabine 44lenvatinib 43Radiosurgery 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Colonoscopy × 1 year × Clear all
NCT07502469 2026-03-31

BENEFIT

Elsan

Completed
341 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT04336397 2025-11-19

Stool DNA to Improve Colorectal Cancer Screening Among Alaska Native People

Alaska Native Tribal Health Consortium

Phase NA Completed
2,029 enrolled 9 charts
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡